OraSure Technologies Appoints New Officers

BETHLEHEM, Pa.--(BW HealthWire)--Feb. 2, 2001--OraSure Technologies, Inc. (Nasdaq:OSUR) today announced the appointment of Richard D. Hooper, 37, as the company's Chief Financial Officer.

Mr. Hooper's appointment follows the retirement of Charles E. Bergeron in connection with the recent merger of Epitope, Inc., and STC Technologies, Inc., into the Company. The Company has also named Jack E. Jerrett as Secretary, Mark L. Kuna as Controller, and Michelle M. Sells as Manager, Investor Relations.

Mr. Hooper has served as Vice President, Finance for OraSure Technologies since September. Prior to that time, Mr. Hooper served as Chief Financial Officer for STC Technologies since October 1997, and as Manager, Finance and Accounting since April 1996. Before joining the Company, Mr. Hooper was a Vice President in PNC Bank's Corporate Banking Group. Mr. Hooper received his BA in Accounting from Moravian College and his MBA from Lehigh University.

Mr. Jerrett joined the Company in November 2000 as Vice President and General Counsel. Prior to joining the Company, Mr. Jerrett served as Associate General Counsel and Senior Counsel at PPL Electric Utilities Corporation since July 1998. Prior to joining PPL, Mr. Jerrett served as Senior Corporate Attorney at Union Pacific Corporation and as an Associate with Morgan, Lewis & Bockius. Mr. Jerrett received his BS in Accounting and Juris Doctor from Villanova University.

Mr. Kuna joined the Company in October 2000 from XO Communications, Inc., where he served as Director of Financial Planning and Analysis. Prior to that, Mr. Kuna was Vice President and Principal Accounting Officer for Wedco Technologies, Inc. Mr. Kuna is a Certified Public Accountant and received his BS in Accounting from the University of Scranton.

Ms. Sells has been promoted to Manager, Investor Relations for OraSure Technologies after holding numerous positions with its predecessor Epitope, Inc., since joining the Company in 1987.

"These management changes will add significant value to the combined company that we have created and the above individuals will be instrumental in the Company's success going forward," said Robert D. Thompson, Chief Executive Officer for OraSure Technologies.

About OraSure Technologies

OraSure Technologies, Inc. develops, manufactures and markets medical devices and diagnostic products for use by public- and private-sector clients, clinical laboratories, physicians' offices and workplace testing. OraSure Technologies is the leading supplier of oral fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV. In addition, the company supplies oral fluid testing solutions for drugs-of-abuse testing. For more information on the company please go to www.orasure.com.

CONTACT:
OraSure Technologies, Inc.
Michelle Sells, 503/641-6115
Investorinfo@orasure.com
www.orasure.com
or
Rich Hooper, 610/882-1820 ext. 3042